2019
DOI: 10.1016/j.jval.2019.09.2554
|View full text |Cite
|
Sign up to set email alerts
|

Prs65 Bevacizumab Induced Pulmonary Embolism: A Disproportionality Analysis in Usfda Adverse Event Reporting System Database

Abstract: Objectives: Extrapulmonary impacts of chronic obstructive pulmonary disease (COPD) often include sleep disturbance, poor sleep quality, and daytime sleepiness resulting in detrimental impact on patients' overall health-related quality of life (HRQoL). This study evaluated the impact of sleep disturbance on HRQoL in patients with COPD. Methods: Literature searches were performed in biomedical databases until March 2019. Specific search terms identified observational studies assessing HRQoL in COPD that included… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles